<p>Oscar Health, Inc.（纽约证券交易所代码：OSCR - 获取免费报告）内部人士 Mario Schlosser 于 12 月 2 日（星期二）出售了 23,965 股公司的股票。该股票的平均售价为 16.59 美元，总交易额为 397,579.35 美元。出售完成后，该内部人士在公司持有 477,183 股，价值 7,916,465.97 美元。这代表其持股比例减少了 4.78%。该交易已在与证券交易委员会的法律文件中披露，您可以通过此链接访问。</p>
<ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
<p>Mario Schlosser 最近还进行了以下交易：</p>
<ul>
<li>在 11 月 11 日（星期二），Mario Schlosser 出售了 286,182 股 Oscar Health 股票。该股票的平均售价为 15.27 美元，总价值为 4,369,999.14 美元。</li>
<li>在 9 月 22 日（星期一），Mario Schlosser 出售了 395,000 股 Oscar Health 股票。该股票的平均售价为 18.43 美元，总价值为 7,279,850.00 美元。</li>
</ul>
<h2>Oscar Health 股票表现</h2>
<p>OSCR 股票在周四的午盘交易中上涨了 0.07 美元，达到 17.17 美元。该股票的交易量为 7,737,399 股，而其平均交易量为 14,589,062 股。Oscar Health, Inc.的股价一年低点为 11.20 美元，一年高点为 23.80 美元。该公司的市值为 45.5 亿美元，市盈率为-15.33，贝塔值为 1.88。该公司的 50 日简单移动平均线为 18.08 美元，200 日简单移动平均线为 16.93 美元。公司的速动比率为 0.92，流动比率为 0.92，债务与股本比率为 0.67。</p>
<p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最近在 11 月 6 日（星期四）发布了其财报。公司报告本季度每股收益（EPS）为（0.53）美元，超出市场共识预期的（0.55）美元，超出幅度为 0.02 美元。该季度公司的收入为 29.3 亿美元，而分析师预期为 30.9 亿美元。Oscar Health 的股本回报率为-21.50%，净利润率为-2.16%。与去年同期相比，Oscar Health 的季度收入增长了 23.2%。去年同期，该公司每股收益为（0.22）美元。分析师平均预测 Oscar Health, Inc.本年度将发布 0.69 美元的每股收益。</p>
<h2>机构投资者对 Oscar Health 的看法</h2>
<p>一些机构投资者最近对 OSCR 的持仓进行了调整。美国世纪公司在第三季度将其在 Oscar Health 的持仓增加了 89.0%。美国世纪公司目前拥有 5,298,340 股该公司的股票，价值 100,298,000 美元，此前在上个季度又购买了 2,495,691 股。Nuveen LLC 在第一季度获得了 Oscar Health 的新持仓，价值约 29,684,000 美元。Farallon Capital Management LLC 在第三季度将其在 Oscar Health 的持仓增加了 146.5%。Farallon Capital Management LLC 目前拥有 3,639,000 股该公司的股票，价值 68,886,000 美元，此前在上个季度又购买了 2,163,000 股。Thrive Capital Management LLC 在第四季度将其在 Oscar Health 的持仓提高了 33.4%。Thrive Capital Management LLC 目前拥有 6,343,617 股该公司的股票，价值 85,258,000 美元，此前在该期间又购买了 1,588,395 股。最后，密歇根州退休系统在第三季度购买了 Oscar Health 的新股份，价值 27,448,000 美元。75.70% 的股票由机构投资者和对冲基金持有。</p>
<h2>分析师的升级和降级</h2>
<p>几位研究分析师最近对该股票发布了报告。富国银行将 Oscar Health 的目标股价从 14.00 美元下调至 11.00 美元，并在 11 月 13 日（星期四）的研究报告中对该公司给予了 “减持” 评级。高盛集团在 10 月 14 日（星期二）对 Oscar Health 进行了覆盖，给予了 “中性” 评级和 17.00 美元的目标价格。派珀·桑德勒将 Oscar Health 的评级从 “中性” 上调至 “增持”，并在 11 月 25 日（星期二）的研究报告中将其目标价格从 13.00 美元提高至 25.00 美元。瑞银集团将 Oscar Health 的目标价格从 11.00 美元上调至 12.00 美元，并在 11 月 7 日（星期五）的研究报告中给予该公司 “卖出” 评级。最后，巴克莱将 Oscar Health 的目标价格从 11.00 美元上调至 13.00 美元，并在 11 月 10 日（星期一）的研究报告中给予该股票 “减持” 评级。一位分析师对该股票给予了买入评级，五位分析师给予了持有评级，五位分析师给予了卖出评级。根据 MarketBeat.com 的数据，Oscar Health 目前的共识评级为 “减持”，共识目标价格为 14.86 美元。</p>
<p><strong>获取我们关于 OSCR 的最新研究报告</strong></p>
<h2>Oscar Health 公司简介</h2>
<p>（获取免费报告）</p>
<p>Oscar Health, Inc.在美国运营，提供健康保险。该公司在个人和小型团体市场提供健康计划，以及 +Oscar，一个技术驱动的平台，帮助提供者和支付方直接实现向基于价值的护理转型。它还提供再保险产品。</p>
<h2>推荐故事</h2>
<ul>
<li>五只我们更看好的股票，而不是 Oscar Health</li>
<li>股票市场行业：它们是什么以及有多少个？</li>
<li>利用 2026 年人工智能基础设施收益的高增长 ETF</li>
<li>内部交易 - 您需要知道的事项</li>
<li>强劲的季度，疲软的反应：为什么 GitLab 的股票下跌</li>
<li>ESG 股票，投资者应了解的事项</li>
<li>特斯拉开始 12 月的三个迹象</li>
</ul>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>您现在应该投资 1,000 美元在 Oscar Health 吗？</h2>
<p>在您考虑 Oscar Health 之前，您需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oscar Health 并不在名单上。</p>
<p>尽管 Oscar Health 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

OSCR

<p>Oscar Health 内部人士 Mario Schlosser 以每股 16.59 美元的价格出售了 23,965 股，总计 397,579.35 美元，减少了 4.78% 的持股比例。他现在拥有 477,183 股，价值 7,916,465.97 美元。此次出售在 SEC 文件中披露。Schlosser 之前在 11 月 11 日和 9 月 22 日出售过股票。还强调了 Oscar Health 的股票表现和机构投资者活动，以及分析师的评级和价格目标</p>

<p>Oscar Health, Inc. (NYSE:OSCR - Get Free Report) insider Mario Schlosser sold 23,965 shares of the firm's stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $16.59, for a total transaction of $397,579.35. Following the completion of the sale, the insider owned 477,183 shares in the company, valued at $7,916,465.97. This represents a 4.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is accessible through this link.</p>
<div class="lb-trans"><p>Oscar Health, Inc.（纽约证券交易所代码：OSCR - 获取免费报告）内部人士 Mario Schlosser 于 12 月 2 日（星期二）出售了 23,965 股公司的股票。该股票的平均售价为 16.59 美元，总交易额为 397,579.35 美元。出售完成后，该内部人士在公司持有 477,183 股，价值 7,916,465.97 美元。这代表其持股比例减少了 4.78%。该交易已在与证券交易委员会的法律文件中披露，您可以通过此链接访问。</p>
</div><ul>
<li>5 Small Cap Stocks With Explosive Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>5 只具有爆炸性上涨潜力的小型股</li>
</ul>
</div><p>Mario Schlosser also recently made the following trade(s):</p>
<div class="lb-trans"><p>Mario Schlosser 最近还进行了以下交易：</p>
</div><ul>
<li>On Tuesday, November 11th, Mario Schlosser sold 286,182 shares of Oscar Health stock. The stock was sold at an average price of $15.27, for a total value of $4,369,999.14.</li>
<li>On Monday, September 22nd, Mario Schlosser sold 395,000 shares of Oscar Health stock. The shares were sold at an average price of $18.43, for a total value of $7,279,850.00.</li>
</ul>
<div class="lb-trans"><ul>
<li>在 11 月 11 日（星期二），Mario Schlosser 出售了 286,182 股 Oscar Health 股票。该股票的平均售价为 15.27 美元，总价值为 4,369,999.14 美元。</li>
<li>在 9 月 22 日（星期一），Mario Schlosser 出售了 395,000 股 Oscar Health 股票。该股票的平均售价为 18.43 美元，总价值为 7,279,850.00 美元。</li>
</ul>
</div><h2>Oscar Health Stock Performance</h2>
<div class="lb-trans"><h2>Oscar Health 股票表现</h2>
</div><p>Shares of OSCR stock traded up $0.07 during mid-day trading on Thursday, reaching $17.17. The stock had a trading volume of 7,737,399 shares, compared to its average volume of 14,589,062. Oscar Health, Inc. has a one year low of $11.20 and a one year high of $23.80. The firm has a market cap of $4.55 billion, a PE ratio of -15.33 and a beta of 1.88. The firm's 50 day simple moving average is $18.08 and its 200 day simple moving average is $16.93. The company has a quick ratio of 0.92, a current ratio of 0.92 and a debt-to-equity ratio of 0.67.</p>
<div class="lb-trans"><p>OSCR 股票在周四的午盘交易中上涨了 0.07 美元，达到 17.17 美元。该股票的交易量为 7,737,399 股，而其平均交易量为 14,589,062 股。Oscar Health, Inc.的股价一年低点为 11.20 美元，一年高点为 23.80 美元。该公司的市值为 45.5 亿美元，市盈率为-15.33，贝塔值为 1.88。该公司的 50 日简单移动平均线为 18.08 美元，200 日简单移动平均线为 16.93 美元。公司的速动比率为 0.92，流动比率为 0.92，债务与股本比率为 0.67。</p>
</div><p>Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Thursday, November 6th. The company reported ($0.53) EPS for the quarter, topping the consensus estimate of ($0.55) by $0.02. The firm had revenue of $2.93 billion during the quarter, compared to analysts' expectations of $3.09 billion. Oscar Health had a negative return on equity of 21.50% and a negative net margin of 2.16%.Oscar Health's quarterly revenue was up 23.2% compared to the same quarter last year. During the same period last year, the business earned ($0.22) earnings per share. On average, analysts forecast that Oscar Health, Inc. will post 0.69 EPS for the current year.</p>
<div class="lb-trans"><p>Oscar Health（纽约证券交易所代码：OSCR - 获取免费报告）最近在 11 月 6 日（星期四）发布了其财报。公司报告本季度每股收益（EPS）为（0.53）美元，超出市场共识预期的（0.55）美元，超出幅度为 0.02 美元。该季度公司的收入为 29.3 亿美元，而分析师预期为 30.9 亿美元。Oscar Health 的股本回报率为-21.50%，净利润率为-2.16%。与去年同期相比，Oscar Health 的季度收入增长了 23.2%。去年同期，该公司每股收益为（0.22）美元。分析师平均预测 Oscar Health, Inc.本年度将发布 0.69 美元的每股收益。</p>
</div><h2>Institutional Investors Weigh In On Oscar Health</h2>
<div class="lb-trans"><h2>机构投资者对 Oscar Health 的看法</h2>
</div><p>A number of institutional investors have recently made changes to their positions in OSCR. American Century Companies Inc. increased its position in Oscar Health by 89.0% during the third quarter. American Century Companies Inc. now owns 5,298,340 shares of the company's stock worth $100,298,000 after buying an additional 2,495,691 shares during the last quarter. Nuveen LLC acquired a new position in shares of Oscar Health during the 1st quarter worth approximately $29,684,000. Farallon Capital Management LLC increased its holdings in shares of Oscar Health by 146.5% during the 3rd quarter. Farallon Capital Management LLC now owns 3,639,000 shares of the company's stock worth $68,886,000 after acquiring an additional 2,163,000 shares during the last quarter. Thrive Capital Management LLC raised its stake in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company's stock valued at $85,258,000 after acquiring an additional 1,588,395 shares during the period. Finally, State of Michigan Retirement System bought a new stake in Oscar Health in the 3rd quarter valued at $27,448,000. 75.70% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>一些机构投资者最近对 OSCR 的持仓进行了调整。美国世纪公司在第三季度将其在 Oscar Health 的持仓增加了 89.0%。美国世纪公司目前拥有 5,298,340 股该公司的股票，价值 100,298,000 美元，此前在上个季度又购买了 2,495,691 股。Nuveen LLC 在第一季度获得了 Oscar Health 的新持仓，价值约 29,684,000 美元。Farallon Capital Management LLC 在第三季度将其在 Oscar Health 的持仓增加了 146.5%。Farallon Capital Management LLC 目前拥有 3,639,000 股该公司的股票，价值 68,886,000 美元，此前在上个季度又购买了 2,163,000 股。Thrive Capital Management LLC 在第四季度将其在 Oscar Health 的持仓提高了 33.4%。Thrive Capital Management LLC 目前拥有 6,343,617 股该公司的股票，价值 85,258,000 美元，此前在该期间又购买了 1,588,395 股。最后，密歇根州退休系统在第三季度购买了 Oscar Health 的新股份，价值 27,448,000 美元。75.70% 的股票由机构投资者和对冲基金持有。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师的升级和降级</h2>
</div><p>Several research analysts recently issued reports on the stock. Wells Fargo &amp; Company dropped their price target on shares of Oscar Health from $14.00 to $11.00 and set an &#34;underweight&#34; rating for the company in a research report on Thursday, November 13th. The Goldman Sachs Group assumed coverage on Oscar Health in a report on Tuesday, October 14th. They issued a &#34;neutral&#34; rating and a $17.00 target price for the company. Piper Sandler raised Oscar Health from a &#34;neutral&#34; rating to an &#34;overweight&#34; rating and boosted their price target for the company from $13.00 to $25.00 in a research note on Tuesday, November 25th. UBS Group upped their price target on Oscar Health from $11.00 to $12.00 and gave the company a &#34;sell&#34; rating in a research report on Friday, November 7th. Finally, Barclays increased their price objective on Oscar Health from $11.00 to $13.00 and gave the stock an &#34;underweight&#34; rating in a research note on Monday, November 10th. One analyst has rated the stock with a Buy rating, five have issued a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat.com, Oscar Health currently has a consensus rating of &#34;Reduce&#34; and a consensus price target of $14.86.</p>
<div class="lb-trans"><p>几位研究分析师最近对该股票发布了报告。富国银行将 Oscar Health 的目标股价从 14.00 美元下调至 11.00 美元，并在 11 月 13 日（星期四）的研究报告中对该公司给予了 “减持” 评级。高盛集团在 10 月 14 日（星期二）对 Oscar Health 进行了覆盖，给予了 “中性” 评级和 17.00 美元的目标价格。派珀·桑德勒将 Oscar Health 的评级从 “中性” 上调至 “增持”，并在 11 月 25 日（星期二）的研究报告中将其目标价格从 13.00 美元提高至 25.00 美元。瑞银集团将 Oscar Health 的目标价格从 11.00 美元上调至 12.00 美元，并在 11 月 7 日（星期五）的研究报告中给予该公司 “卖出” 评级。最后，巴克莱将 Oscar Health 的目标价格从 11.00 美元上调至 13.00 美元，并在 11 月 10 日（星期一）的研究报告中给予该股票 “减持” 评级。一位分析师对该股票给予了买入评级，五位分析师给予了持有评级，五位分析师给予了卖出评级。根据 MarketBeat.com 的数据，Oscar Health 目前的共识评级为 “减持”，共识目标价格为 14.86 美元。</p>
</div><p><strong>Get Our Latest Research Report on OSCR</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 OSCR 的最新研究报告</strong></p>
</div><h2>Oscar Health Company Profile</h2>
<div class="lb-trans"><h2>Oscar Health 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.</p>
<div class="lb-trans"><p>Oscar Health, Inc.在美国运营，提供健康保险。该公司在个人和小型团体市场提供健康计划，以及 +Oscar，一个技术驱动的平台，帮助提供者和支付方直接实现向基于价值的护理转型。它还提供再保险产品。</p>
</div><h2>Recommended Stories</h2>
<div class="lb-trans"><h2>推荐故事</h2>
</div><ul>
<li>Five stocks we like better than Oscar Health</li>
<li>Stock Market Sectors: What Are They and How Many Are There?</li>
<li>Tap Into 2026 AI Infrastructure Gains With This High-Growth ETF</li>
<li>Insider Trading - What You Need to Know</li>
<li>Strong Quarter, Weak Reaction: Why GitLab Shares Dropped</li>
<li>ESG Stocks, What Investors Should Know</li>
<li>3 Signs Tesla Is Starting December on the Front Foot</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，而不是 Oscar Health</li>
<li>股票市场行业：它们是什么以及有多少个？</li>
<li>利用 2026 年人工智能基础设施收益的高增长 ETF</li>
<li>内部交易 - 您需要知道的事项</li>
<li>强劲的季度，疲软的反应：为什么 GitLab 的股票下跌</li>
<li>ESG 股票，投资者应了解的事项</li>
<li>特斯拉开始 12 月的三个迹象</li>
</ul>
</div><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Oscar Health Right Now?</h2>
<div class="lb-trans"><h2>您现在应该投资 1,000 美元在 Oscar Health 吗？</h2>
</div><p>Before you consider Oscar Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在您考虑 Oscar Health 之前，您需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oscar Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而 Oscar Health 并不在名单上。</p>
</div><p>While Oscar Health currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>尽管 Oscar Health 目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Oscar Health (NYSE:OSCR) 内部人士 Mario Schlosser 出售了 23,965 股股票